Antihypertensive effect of Nigella sativa seed extract in patients with mild hypertension

Fundamental and Clinical Pharmacology

Volumn 22, Issue 4, 2008, Pages 447-452

  Dehkordi, Farshad Roghani ^a   Kamkhah, Amir Farhad ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypertension; Nigella sativa; Randomized controlled study

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; NIGELLA SATIVA EXTRACT; ANTIHYPERTENSIVE AGENT; ESSENTIAL OIL; PLANT EXTRACT;

ADULT; ARTICLE; BLACK CUMIN; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; HUMAN; HUMAN EXPERIMENT; HYPERTENSION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; MIDDLE AGED; ORAL DRUG ADMINISTRATION; PHYTOTHERAPY; PLANT SEED;

ADMINISTRATION, ORAL; ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIGELLA SATIVA; OILS, VOLATILE; PHYTOTHERAPY; PLANT EXTRACTS; SEEDS;

EID: 55949121968     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2008.00607.x     Document Type: Article

References (30)

1. Domanski M., Mitchell G., Pfeffer M. et al. Pulse pressure and cardiovascular disease-related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA (2002) 287 2677-2683.
2. Whelton P.K., He J., Appel L.J. et al. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA (2002) 288 1882-1888.
3. Japanese Society of Hypertension Guidelines Subcommittee for the Management of Hypertension. Guidelines for the management of hypertension for general practitioners. Hypertens. Res. (2001) 24 613-634.
4. FitzGerald R.J., Murray B.A., Walsh D.J. Hypotensive peptides from milk proteins. J. Nutr. (2004) 134 980S-988S.
5. Ferrari C.K. Functional foods, herbs and nutraceuticals: towards biochemical mechanisms of healthy aging. Biogerontology (2004) 5 275-89.
6. Yao L.H., Jiang Y.M., Shi J et al. Flavonoids in food and their health benefits. Plant Foods Hum. Nutr. (2004) 59 113-122.
7. Mills S. Monitoring herbal safety: current debate and resources. Symposium Report: Pharmacovigilance of Herbal Medicines: Current State and Future Direction, London, 24-26 April 2006. Phytomedicine (2007) in press.
8. Ali B.H., Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother. Res. (2003) 17 299-305.
9. Bamosa A.O., Ali B.A., Sowayan S.A. Effect of oral ingestion of Nigella sativa seed on some blood parameters. Saudi Pharm. J. (1997) 5 126-9.
10. Bamosa A.O., Basil A.A., Zubaida A.A. The effect of thymo-quinone on blood lipids in rats. Indian J. Pharmacol. (2002) 46 195-201.
11. Kanter M., Meral I., Dede S. et al. Effects of Nigella sativa L. and Urtica dioica L. on lipid peroxidation, antioxidant enzyme systems and some liver enzymes in CCl4-treated rats. J. Vet. Med. A. Physiol. Pathol. Clin. Med. (2003) 50 264-8.
12. Mahfouz M., El-Dakhakhny M. Some chemical and pharmacological properties of the new anti-asthmatic drug, Nigellone. Egypt. Pharm. Bull. (1960) 42 411-24.
13. Toppozada H.H., Mazloum H.A., El Dakhakhny M. The antibacterial properties of the Nigella sativa l. Seeds. Active principle with some clinical applications. J. Egypt. Med. Assoc. (1965) 48 (Suppl-202) 187-202.
14. el Tahir K.E., Ashour M.M., al Harbi M.M. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: elucidation of the mechanism of action. Gen. Pharmacol. (1993) 24 1123-31.
15. Zaoui A., Cherrah Y., Lacaille-Dubois M.A., Settaf A., Ama-rouch H., Hassar M. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat. Therapie (2000) 55 379-82.
16. Ghosheh O.A., Houdi A.A., Crooks P.A. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.). J. Pharm. Biomed. Anal. (1999) 19 757-762.
17. Burits M., Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother. Res. (2000) 14 323-328.
18. Mansour M.A., Ginawi O.T., El-Hadiyah T., El-Khatib A.S., Al-Shabanah O.A., Al-Sawaf H.A. Effects of volatile oil constituents of Nigella sativa on carbon tetrachloride-induced hepato-toxicity in mice: evidence for antioxidant effects of thymoquinone. Res. Commun. Mol. Pathol. Pharmacol. (2001) 110 239-51.
19. Eichholzer M., Stahelin H.B., Gey K.F. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke. EXS (1992) 62 398-410.
20. Gey K.f., Stahelin H.B., Eicholzer M. Poor plasma status of carotene and vitamin C is associated with a higher mortality from ischemic heart disease and stroke: basal prospective study. Clin. Invest. (1993) 71 3-6.
21. Redon J., Oliva M.R., Tormos C. et al. Antioxidant activities and oxidative stress byproducts in human hypertension. Hypertension (2003) 41 1096-1101.
22. Noguchi T., Ikeda K., Sasaki Y. et al. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens. Res. (2001) 24 735-742.
23. Mullan B.A., Young I.S., Fee H., MaCance D.R. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension (2002) 40 804-809.
24. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. (1993) 328 1450-6.
25. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomized controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet (1996) 347 781-6.
26. Stein J.H., Keevil J.G., Wiebe DA., Aeschlimann S., Folts J.D. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation (1999) 100 1050-5.
27. Appel L.J., Moore T.J., Obarzanek E. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. (1997) 336 1117-24.
28. Andrade J.P., Vilas-Boas F., Chagas H., Andrade M. Epidemi-ological aspects of adherence to the treatment of hypertension. Arq. Bras. Cardiol. (2002) 79 375-84.
29. Wong N.D., Lopez V., Tang S., Williams G.R. Prevalence, treatment, and control of combined hypertension and hyper-cholesterolemia in the United States. Am. J. Cardiol. (2006) 98 204-8.
30. Johnson M.L., Pietz K., Battleman D.S., Beyth R.J. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. Am. J. Manage. Care. (2004) 10 926-32.